Endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 involves ceramide metabolic pathways

Blood

Volumn 105, Issue 11, 2005, Pages 4353-4361

  Erdreich Epstein, Anat ^a   Tran, Linda B ^b   Cox, Órla T ^b   Huang, Elaine Y ^b   Laug, Walter E ^b   Shimada, Hiroyuki ^b   Millard, Melissa ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; CERAMIDE; CYCLOARGINYLGLYCYLASPARTYLASPARTYLPHENYLALANYLVALINE; DESIPRAMINE; FANTOFARONE; IMIPRAMINE; POLYLYSINE; PROTEIN INHIBITOR; SPHINGOMYELIN; THERMOZYMOCIDIN; UNCLASSIFIED DRUG; VITRONECTIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANOIKIS; APOPTOSIS; ARTICLE; CELL LEVEL; CELL SPREADING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; LIPOGENESIS; PRIORITY JOURNAL;

EID: 19344363059     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-08-3098     Document Type: Article

References (72)

1. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
2. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
3. Martin KH, Slack JK, Boerner SA, Martin CC, Parsons JT. Integrin connections map: to infinity and beyond. Science. 2002;296:1652-1653.
4. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104:1606-1615.
5. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin αvβ3 for angiogenesis. Science. 1994;264:569-571.
6. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
7. Brooks PC, Stromblad S, Klemke R, et al. Anti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995;96:1815-1822.
8. Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathways by distinct αv integrins. Science. 1995;270:1500-1502.
9. Friedlander M, Theesfeld CL, Sugita M, et al. Involvement of integrins αvβ3 and αvβ5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996;93:9764-9769.
10. Aumailley M, Gurrath M, Muller G, et al. Arg-Gly-Asp constrained within cyclic pentapeptides: strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 1991;291:50-54.
11. MacDonald TJ, Taga T, Shimada H, et al. Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery. 2001;48:151-157.
12. Stromblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. Suppression of p53 activity and P21WAF1/CIP1 expression by vascular cell integrin αVβ3 during angiogenesis. J Clin Invest. 1996;98:426-433.
13. Scatena M, Almeida M, Chaisson ML, et al. NFκB mediates αvβ3 integrin-induced endothelial cell survival. J Cell Biol. 1998;141:1083-1093.
14. Gutheil JC, Campbell TN, Pierce PR, et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3. Clin Cancer Res. 2000;6:3056-3061.
15. Eskens FA, Dumez H, Hoekstra R, et al. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours. Eur J Cancer. 2003;39:917-926.
16. Tucker GC. Alpha v integrin inhibitors and cancer therapy. Curr Opin Investig Drugs. 2003;4:722-731.
17. Trikha M, Zhou Z, Nemeth JA, et al. CNTO 95, a fully human monoclonal antibody that inhibits alpha-v integrins, has antitumor and antiangiogenic activity in vivo. Int J Cancer 2004;110:326-335.
18. Stromblad S, Fotedar A, Brickner H, et al. Loss of p53 compensates for alpha-v integrin function in retinal neovascularization. J Biol Chem. 2002; 277:13371-13374.
19. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol. 2001;155:459-470.
20. Reynolds LE, Wyder U, Lively JC, et al. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med. 2002;8:27-34.
21. Mathias S, Pena LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J. 1998; 335:465-480.
22. Obeid LM, Hannun YA. Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem. 1995;58:191-198.
23. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380:75-79.
24. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996; 274:1855-1859.
25. Erdreich-Epstein A, Tran LB, Bowman NN, et al. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J Biol Chem. 2002;277: 49531-49537.
26. Santana P, Pena LA, Haimovitz-Friedman A, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 1996;86:189-199.
27. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300:1155-1159.
28. Kroesen BJ, Pettus B, Luberto C, et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem. 2001;276: 13606-13614.
29. Merrill AHJ. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 2002;277:25843-25846.
30. Basu S, Bayoumy S, Zhang Y, Lozano J, Kolesnick R. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem. 1998;273: 30419-30426.
31. Chalfant CE, Rathman K, Pinkerman RL, et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells: dependence on protein phosphatase-1. J Biol Chem. 2002;277:12587-12595.
32. Bourbon NA, Yun J, Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem. 2000;275:35617-35623.
33. Erdreich-Epstein A, Shimada H, Groshen S, et al. Integrins αvβ3 and αvβ5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 2000;60:712-721.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
35. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol. 1997;76:81-90.
36. Paris F, Grassme H, Cremesti A, et al. Natural ceramide reverses Fas resistance of acid sphingomyelinase (-/-) hepatocytes. J Biol Chem. 2001;276:8297-8305.
37. Lavie Y, Cao H, Volner A, et al. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem. 1997;272: 1682-1687.
38. Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem. 1996; 271:19530-19536.
39. Erdreich-Epstein A, Liu M, Liu Y, Durden DL. Protein tyrosine phosphatase inhibitors in FcγRI-induced myeloid oxidant signaling. Exp Cell Res. 1997;237:288-295.
40. Erdreich-Epstein A, Liu M, Kant AM, et al. Cbl functions downstream of Src kinases in FcγRI signaling in primary human macrophages. J Leukoc Biol. 1999;65:523-534.
41. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-626.
42. Mould AP, Akiyama SK, Humphries MJ. Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations: evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J Biol Chem. 1995;270:26270-26277.
43. Dertinger SK, Jiang X, Li Z, Murthy VN, Whitesides GM. Gradients of substrate-bound laminin orient axonal specification of neurons. Proc Natl Acad Sci U S A. 2002;99:12542-12547.
44. Taga T, Suzuki A, Gonzalez-Gomez I, et al. αv-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int J Cancer 2002;98:690-697.
45. Dejana E, Lampugnani MG, Giorgi M, Gaboli M, Marchisio PC. Fibrinogen induces endothelial cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor. Blood. 1990;75: 1509-1517.
46. Unemori EN, Bouhana KS, Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem. 1990;265:445-451.
47. Kowalczyk AP, Tulloh RH, McKeown-Longo PJ. Polarized fibronectin secretion and localized matrix assembly sites correlate with subendothelial matrix formation. Blood. 1990;75:2335-2342.
48. Papadimitriou E, Manolopoulos VG, Hayman GT, et al. Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. Am J Physiol. 1997;272:C1112-C1122.
49. Kim S, Harris M, Varner JA. Regulation of integrin αvβ3- mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A. J Biol Chem. 2000;275:33920-33928.
50. Thomas RL Jr, Matsko CM, Lotze MT, Amoscato AA. Mass spectrometric identification of increased C16 ceramide levels during apoptosis. J Biol Chem. 1999;274:30580-30588.
51. Kroesen BJ, Jacobs S, Pettus BJ, et al. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J Biol Chem. 2003;278:14723-14731.
52. Chalfant CE, Ogretmen B, Galadari S, et al. FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. J Biol Chem. 2001;276:44848-44855.
53. Lovat PE, Di Sano F, Corazzari M, et al. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. J Natl Cancer Inst. 2004;96:1288-1299.
54. Ramer R, Weinzierl U, Schwind B, Brune K, Hinz B. Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Mol Pharmacol. 2003;64:1189-1198.
55. Grassme H, Cremesti A, Kolesnick R, Gulbins E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene. 2003;22:5457-5470.
56. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997;186:1831-1841.
57. Haimovitz-Friedman A, Kan CC, Ehleiter D, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med. 1994;180:525-535.
58. Dbaibo GS, El-Assaad W, Krikorian A, et al. Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett. 2001;503:7-12.
59. Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta. 2002;1585:114-125.
60. Le Stunff H, Galve-Roperh I, Peterson C, Milstien S, Spiegel S. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J Cell Biol. 2002;158:1039-1049.
61. Radin NS. Apoptotic death by ceramide: will the real killer please stand up? Med Hypotheses. 2001;57:96-100.
62. Gulbins E, Kolesnick R. Raft ceramide in molecular medicine. Oncogene. 2003;22:7070-7077.
63. McDonald JF, Zheleznyak A, Frazier WA. Cholesterol-independent interactions with CD47 enhance αvβ3 avidity. J Biol Chem. 2004;279: 17301-17311.
64. Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA. Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol. 2003;162:933-943.
65. Byzova VT, Goldman KC, Pampori N, et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell. 2000;6:851-860.
66. Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase C zeta: implications for growth arrest. J Biol Chem. 2002;277:3286-3292.
67. Sawada M, Nakashima S, Kiyono T, et al. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Exp Cell Res. 2002;273:157-168.
68. Cohen O, Feinstein E, Kimchi A. DAP-kinase is a Ca2+/calmodulin- dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997;16:998-1008.
69. Wang WJ, Kuo JC, Yao CC, Chen RH. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol. 2002;159:169-179.
70. Pelled D, Raveh T, Riebeling C, et al. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem. 2002;277:1957-1961.
71. Yamamoto M, Hioki T, Ishii T, Nakajima-Iijima S, Uchino S. DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells. Eur J Biochem. 2002;269:139-147.
72. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science. 1997;276:1425-1428.